sumi.news
Search
Following
Sign in
← Back to news
Y
Yahoo Finance
RSS Feed
finance.yahoo.com
finance.yahoo.com/rss
Follow
Latest
Sun Nov 23
Alkami Technology (ALKT): Jana Lauds Organic Top Line Growth
2d
Y
Intel stock soared in 2025. But the chipmaker still has a long road ahead.
2d
Y
Chevron Could Raise Its Dividend Next Month - CVX Stock Looks Too Cheap
2d
Y
25 Reasons to Buy Joby Aviation Stock for 2026
2d
Y
‘DeFi is dead’: Maple Finance’s CEO says onchain markets will swallow Wall Street
2d
Y
The Stock Market’s Wild 2025 Roller-Coaster Ride in Six Charts
2d
Y
Upstart Holdings (UPST): Firm Announces New Castlelake Deal
2d
Y
Corcept Therapeutics (CORT): Analyst Says Shares Pricing in Growth, New Launch
2d
Y
Clearwater Analytics Holdings (CWAN): Activist Investor Wants Share Price Boost
2d
Y
Wingstop (WING): RBC Highlights Growth, Long US Runway
2d
Y
ADMA Biologics (ADMA): Firm Updates 2025 Revenue Guidance
2d
Y
Dutch Bros (BROS): KeyBanc Highlights Compelling Growth Story
2d
Y
Why Warren Buffett Just Sold 15% of His Apple Stake and Is Putting Money Here Instead
2d
Y
VOO vs. MGK: Is S&P 500 Diversification or Mega-Cap Growth the Better Buy for Investors?
2d
Y
The Stock Market Is Doing Something It's Only Done Twice Since 1871 -- Should You Be Worried for 2026?
2d
Y
Jeff Bezos warned Americans not to buy a new 'refrigerator, or whatever.’ Fearmongering, or good advice for 2026?
2d
Y
Here's your big free reminder on AI stocks for 2026
2d
Y
Prediction: This Data Center REIT Could Double as AI Demand Soars
2d
Y
The Secret to Finding the Next Broadcom Is Hiding in Plain Sight
2d
Y
How Much Should You Have Saved To Retire at 65?
2d
Y
SPGM vs. VT: Which Global ETF Is the Better Buy for Investors?
2d
Y
Half of US Homes Have Lost Value This Year: Is the Market Cooling or Collapsing?
2d
Y
Ellison’s hardball Warner Bros. tactics gave Netflix an opening
2d
Y
Advisors Target Diversification in 2026 Strategies as Mag 7 Risk Rises
2d
Y
Amazon Stock in 2026: Key Catalysts and What Investors Should Watch
2d
Y
Private Equity must Invest 'Dry Powder' or Risk an Investor Exodus
2d
Y
Which Small-Cap ETF Is Better: Vanguard's VB or iShares' ISCB?
2d
Y
If You'd Invested $500 in Netflix 10 Years Ago, Here's How Much You'd Have Today
2d
Y
After my divorce I ended up with a truck $7K underwater. Here are the best ways to manage your debt
2d
Y
Stocks enter final stretch of 2025 just off record highs: What to watch this week
2d
Y
Coty Completes Wella Divestment to Refocus on Fragrances
2d
Y
Denison Mines Forms Joint Ventures With Skyharbour
2d
Y
Jefferies Sees Structural Strength but Limited Upside for UWM Holdings Corporation (UWMC)
2d
Y
Wall Street Keeps B2Gold Corp. (BTG) in Focus With Mixed Views
2d
Y
BlackBerry Limited (BB) Outperforms Estimates but RBC Sticks With Sector Perform
2d
Y
Is Recursion Pharmaceuticals, Inc. (RXRX) the Best Fundamentally Strong Penny Stock to Buy?
2d
Y
NIO Inc. (NIO) Holds Mixed Analyst Sentiment Despite Strong Median Upside Potential
2d
Y
Clarivate Plc (CLVT) Downgraded Amid Turnaround Challenges
2d
Y
Cosan S.A. (CSAN) Gets Negative Outlook from Fitch as Leverage Remains High
2d
Y
Could This Bear-Market Buy Help You Become a Millionaire?
2d
Y
Prediction: These 3 Stocks Will Join the $3 Trillion Club in 2026
2d
Y
Bullish Analyst Sentiment on Fulcrum Therapeutics (FULC) Following Positive Updates from Phase 1b PIONEER Study
2d
Y
Taysha Gene (TSHA) Hovers Around Its 52-Week High As It Continues to Advance Rett Syndrome Program
2d
Y
High Analyst Confidence on Palvella Therapeutics (PVLA) Following Encouraging Phase 2 Data for QTORIN Rapamycin
2d
Y
Gossamer Bio (GOSS) Sees Strong Analyst Confidence Amid Seralutinib Progress and Upcoming PROSERA Data
2d
Y
Strong REZOLVE-AA Study Results Drive Analyst Confidence in Nektar Therapeutics (NKTR)
2d
Y
Trevi Therapeutics (TRVI) Targets Next Phase of Growth with Leadership Change
2d
Y
Analysts Remain Bullish on Seabridge Gold (SA) Amid KSM Project Progress
2d
Y
TD Cowen Initiates Coverage on RAPT Therapeutics (RAPT) with a “Buy”
2d
Y
Analysts Bullish as Ventyx Biosciences (VTYX) Advances Its Clinical and Strategic Initiatives
2d
Y
More →